FUSION
Fusion Pharmaceuticals Inc.
Mark For: FUSION™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90447045 |
| Mark Literal Elements | FUSION |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED 2022-01-10 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Jonathan M. Gelchinsky |
| Attorney Name | Jonathan M. Gelchinsky |
| Attorney Docket Number | 37653/3000F |
Timeline
| 2021-01-04 | Application Filed |
| 2021-01-07 | Location: NEW APPLICATION PROCESSING |
| 2021-01-07 | Status: Live/Pending |
| 2021-01-07 | Transaction Date |
| 2022-01-10 | Location: TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED |
| 2022-01-10 | Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi |
Trademark Parties (Applicants & Owners)
| Party: |  Fusion Pharmaceuticals Inc. |
| Address | 270 Longwood Road South Hamilton, Ontario CANADA L8P0A6 |
| Legal Entity Type | Corporation |
| Legal Entity State | CANADA |
Documents
 Application | 2021-01-04 | |
| Drawing | 2021-01-04 | |
| Offc Action Outgoing | 2021-07-22 | |
| XSearch Search Summary | 2021-07-22 | |
| Offc Action Outgoing | 2022-01-10 | |
| Response to Office Action | 2022-07-08 | |
| Amendment and Mail Process Complete | 2022-07-09 | |
| TRAM Snapshot of App at Pub for Oppostn | 2022-08-09 | |
| Notice of Publication | 2022-08-24 | |
| Notification Of Notice of Publication | 2022-08-24 | |
| OG Publication Confirmation | 2022-09-13 | |
| Notice of Allowance | 2022-11-08 | |
| Extension of Time to File SOU | 2023-05-02 | |
| ITU Extension Approval | 2023-05-04 | |
| ITU Unit Action | 2023-05-04 | |
| Specimen | 2023-05-15 | |
| Statement of Use | 2023-05-15 | |
| ITU Unit Action | 2023-06-07 | |
| Notice of Acceptance of Statement of Use | 2023-06-09 | |
| TRAM Snapshot of App at Pub for Oppostn | 2023-06-09 | |
| Notice of Registration-Notice | 2023-07-11 | |
| Registration Certificate | 2023-07-11 |
Attorney of Record
Good, Services, and Codes
IC 001. US 001 005 006 010 026 046. G & S: Bifunctional chelate material to be used in drug discovery, pharmaceutical development and clinical research
IC 005. US 005 006 018 044 046 051 052. G & S: Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells, including but not limited to cancer cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0011 | Bifunctional chelate material to be used in drug discovery, pharmaceutical development and clinical research |
| GS0051 | Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use |
Assignments
| Description | Date |
|---|---|
 Trademark Assignment 7685-0527 [12 Pages] | 2022-04-08 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2023-07-11 | |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-07-11 | |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2023-06-09 | |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2023-06-08 | |
| STATEMENT OF USE PROCESSING COMPLETE | 2023-06-06 | |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2023-06-06 | |
| USE AMENDMENT FILED | 2023-05-15 | |
| TEAS STATEMENT OF USE RECEIVED | 2023-05-15 | |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-05-04 | |
| SOU TEAS EXTENSION RECEIVED | 2023-05-02 | |
| SOU EXTENSION 1 GRANTED | 2023-05-02 | |
| SOU EXTENSION 1 FILED | 2023-05-02 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-11-08 | |
| PUBLISHED FOR OPPOSITION | 2022-09-13 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-09-13 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-08-24 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-08-06 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-07-08 | |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-07-08 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-07-08 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-01-10 | |
| NON-FINAL ACTION WRITTEN | 2022-01-10 | |
| NON-FINAL ACTION E-MAILED | 2022-01-10 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-07-22 | |
| NON-FINAL ACTION WRITTEN | 2021-07-22 | |
| NON-FINAL ACTION E-MAILED | 2021-07-22 | |
| ASSIGNED TO EXAMINER | 2021-07-12 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-04-02 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2021-04-02 | |
| NEW APPLICATION ENTERED IN TRAM | 2021-01-07 | |
| NEW APPLICATION ENTERED | 2021-01-07 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 